Hawryluk P. Kent
President & CEO
Hawryluk P. Kent has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 8, 2026.
On the most recent filing, Hawryluk P. Kent is listed as President & CEO at MBX Biosciences, Inc. Inside the rolling window, Hawryluk P. Kent reported 1 open-market purchase totaling $526K in MBX and 1 open-market sale totaling $18K in MBX. The largest disclosed transaction in the window is a purchase of 18,500 MBX shares on Mar 13, 2026, worth $526K.
Companies traded
Other insiders at MBX
Insider Buying
$526K
reported purchases (SEC code P)
Insider Selling
$18K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 20, 2025 | MBX | Purchase | $273K |
Frequently asked questions
How many SEC Form 4 filings has Hawryluk P. Kent made?
Hawryluk P. Kent has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Hawryluk P. Kent trade?
Hawryluk P. Kent has filed SEC Form 4 disclosures for 1 company, including MBX.
When was Hawryluk P. Kent's most recent SEC Form 4 filing?
Hawryluk P. Kent's most recent SEC Form 4 filing on Tracefour is dated May 8, 2026.
What is Hawryluk P. Kent's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hawryluk P. Kent is listed as President & CEO.
What is Hawryluk P. Kent's total buy and sell value in the current window?
Inside the rolling retention window, Hawryluk P. Kent bought $526K and sold $18K based on SEC Form 4 filings.
What was Hawryluk P. Kent's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 18,500 MBX shares on 2026-03-13, worth $526K, per SEC Form 4 filings.